{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:44:57Z","timestamp":1794941097156,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies have investigated the association between the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C) and the incidence of diabetes in adults and discovered that a high TG\/HDL-C ratio was linked to an elevated risk of new-onset diabetes. However, the comparison of predicting diabetes development among lipid profiles including the TG\/HDL-C ratio, and the ratio of TG\/HDL-C cut-off value has received limited attention. We examined the relationship between diabetes onset and the TG\/HDL-C ratio in addition to the applicable cut-off value for predicting diabetes onset.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 120,613 participants from the health examination database at Panasonic Corporation from 2008 to 2017. Cox regression analysis employing multivariable models was used to investigate the association between lipid profiles, particularly the ratio of TG\/HDL-C and the development of type 2 diabetes (T2D). The multivariable model was adjusted for age, sex, BMI, systolic blood pressure, plasma glucose levels after fasting, smoking status, and exercise habits. Areas under time-dependent receiver operating characteristic (ROC) curves (AUCs) were employed to assess the prediction performance and cut-off values of each indicator. A fasting plasma glucose level of 126\u00a0mg\/dL, a self-reported history of diabetes, or usage of antidiabetic medicines were used to identify T2D.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the course of the study, 6,080 people developed T2D. The median follow-up duration was 6.0 (3\u201310) years. Multivariable analysis revealed that the ratio of TG\/HDL-C (per unit, HR; 1.03 [95% CI 1.02\u20131.03]) was substantially linked to the risk of incident T2D. AUC and cut-off points for the ratio of TG\/HDL-C for T2D development after 10\u00a0years were 0.679 and 2.1, respectively. Furthermore, the AUC of the ratio of TG\/HDL-C was considerably larger compared to that of LDL-C, HDL-C, and TG alone (all P\u2009&lt;\u20090.001). We discovered an interaction effect between sex, BMI, and lipid profiles in subgroup analysis. Females and participants having a BMI of\u2009&lt;\u200925\u00a0kg\/m<jats:sup>2<\/jats:sup> showed a higher correlation between lipid profile levels and T2D onset.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The ratio of TG\/HDL-C was found to be a stronger predictor of T2D development within 10\u00a0years than LDL-C, HDL-C, or TG, indicating that it may be useful in future medical treatment support.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-02046-5","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:02:25Z","timestamp":1699459345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Triglycerides\/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10"],"prefix":"10.1186","volume":"22","author":[{"given":"Hiroki","family":"Yuge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushiro","family":"Kurogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"2046_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"2046_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"SRK Seshasai","year":"2011","unstructured":"Seshasai SRK, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829\u201341. https:\/\/doi.org\/10.1056\/NEJMoa1008862.","journal-title":"N Engl J Med"},{"issue":"7550","key":"2046_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1136\/bmj.38793.468449.AE","volume":"332","author":"J Costa","year":"2006","unstructured":"Costa J, Borges M, David C, et al. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: Meta-analysis of randomised controlled trials. BMJ. 2006;332(7550):1115\u201324. https:\/\/doi.org\/10.1136\/bmj.38793.468449.AE.","journal-title":"BMJ"},{"issue":"6","key":"2046_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.diabet.2017.08.002","volume":"43","author":"K Fujihara","year":"2017","unstructured":"Fujihara K, Matsubayashi Y, Yamamoto M, et al. Impact of body mass index and metabolic phenotypes on coronary artery disease according to glucose tolerance status. Diabetes Metab. 2017;43(6):543\u20136. https:\/\/doi.org\/10.1016\/j.diabet.2017.08.002.","journal-title":"Diabetes Metab"},{"issue":"12","key":"2046_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","volume":"63","author":"L Wu","year":"2014","unstructured":"Wu L, Parhofer KG. Diabetic dyslipidemia. Metabolism. 2014;63(12):1469\u201379. https:\/\/doi.org\/10.1016\/j.metabol.2014.08.010.","journal-title":"Metabolism"},{"issue":"1","key":"2046_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/MOL.0b013e3283412279","volume":"22","author":"A von Eckardstein","year":"2011","unstructured":"von Eckardstein A, Sibler RA. Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol. 2011;22(1):26\u201332. https:\/\/doi.org\/10.1097\/MOL.0b013e3283412279.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"2046_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.clnu.2017.06.018","volume":"37","author":"D Lin","year":"2018","unstructured":"Lin D, Qi Y, Huang C, et al. Associations of lipid parameters with insulin resistance and diabetes: a population-based study. Clin Nutr. 2018;37(4):1423\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2017.06.018.","journal-title":"Clin Nutr"},{"issue":"4","key":"2046_CR8","doi-asserted-by":"publisher","first-page":"e0154345","DOI":"10.1371\/journal.pone.0154345","volume":"11","author":"X Ren","year":"2016","unstructured":"Ren X, Chen ZA, Zheng S, et al. Association between triglyceride to HDL-C ratio (TG\/HDL-C) and insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus. PLoS ONE. 2016;11(4):e0154345. https:\/\/doi.org\/10.1371\/journal.pone.0154345.","journal-title":"PLoS ONE"},{"key":"2046_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12944-016-0270-z","volume":"15","author":"M Zhou","year":"2016","unstructured":"Zhou M, Zhu L, Cui X, et al. The triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a predictor of insulin resistance but not of \u03b2 cell function in a Chinese population with different glucose tolerance status. Lipids Health Dis. 2016;15:104. https:\/\/doi.org\/10.1186\/s12944-016-0270-z.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"2046_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/liv.12977","volume":"36","author":"Y Fukuda","year":"2016","unstructured":"Fukuda Y, Hashimoto Y, Hamaguchi M, et al. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int. 2016;36(5):713\u201320. https:\/\/doi.org\/10.1111\/liv.12977.","journal-title":"Liver Int"},{"issue":"1","key":"2046_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12944-018-0776-7","volume":"17","author":"C Chen","year":"2018","unstructured":"Chen C, Dai JL. Triglyceride to high-density lipoprotein cholesterol (HDL-C) ratio and arterial stiffness in Japanese population: a secondary analysis based on a cross-sectional study. Lipids Health Dis. 2018;17(1):130. https:\/\/doi.org\/10.1186\/s12944-018-0776-7.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2046_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-021-01330-6","volume":"20","author":"Z Wu","year":"2021","unstructured":"Wu Z, Zhou D, Liu Y, et al. Association of TyG index and TG\/HDL-C ratio with arterial stiffness progression in a non-normotensive population. Cardiovasc Diabetol. 2021;20(1):134. https:\/\/doi.org\/10.1186\/s12933-021-01330-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2046_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-021-01377-5","volume":"20","author":"J Kim","year":"2021","unstructured":"Kim J, Shin SJ, Kim YS, et al. Positive association between the ratio of triglycerides to high-density lipoprotein cholesterol and diabetes incidence in Korean adults. Cardiovasc Diabetol. 2021;20(1):183. https:\/\/doi.org\/10.1186\/s12933-021-01377-5.","journal-title":"Cardiovasc Diabetol"},{"key":"2046_CR14","doi-asserted-by":"publisher","first-page":"108150","DOI":"10.1016\/j.diabres.2020.108150","volume":"163","author":"TK Lim","year":"2020","unstructured":"Lim TK, Lee HS, Lee YJ, et al. Triglyceride to HDL-cholesterol ratio and the incidence risk of type 2 diabetes in community dwelling adults: a longitudinal 12-year analysis of the Korean genome and epidemiology study. Diabetes Res Clin Pract. 2020;163:108150. https:\/\/doi.org\/10.1016\/j.diabres.2020.108150.","journal-title":"Diabetes Res Clin Pract"},{"key":"2046_CR15","doi-asserted-by":"publisher","first-page":"828581","DOI":"10.3389\/fendo.2022.828581","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu H, Liu J, Liu J, et al. Triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio, a simple but effective indicator in predicting type 2 diabetes mellitus in older adult. Front Endocrinol (Lausanne). 2022;13:828581. https:\/\/doi.org\/10.3389\/fendo.2022.828581.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2046_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13098-023-00988-0","volume":"15","author":"M Tohidi","year":"2023","unstructured":"Tohidi M, Asgari S, Chary A, et al. Association of triglycerides to high-density lipoprotein cholesterol ratio to identify future prediabetes and type 2 diabetes mellitus: over one-decade follow-up in the Iranian population. Diabetol Metab Syndr. 2023;15:13. https:\/\/doi.org\/10.1186\/s13098-023-00988-0.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2046_CR17","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1038\/s41598-022-25585-5","volume":"13","author":"H Wang","year":"2023","unstructured":"Wang H, Wang C, Xuan X, et al. Association between triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes risk in Japanese. Sci Rep. 2023;13(1):3719. https:\/\/doi.org\/10.1038\/s41598-022-25585-5.","journal-title":"Sci Rep"},{"key":"2046_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1476-511X-9-85","volume":"9","author":"F Hadaegh","year":"2010","unstructured":"Hadaegh F, Hatami M, Tohidi M, et al. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis. 2010;9:85. https:\/\/doi.org\/10.1186\/1476-511X-9-85.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2046_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12902-022-00984-x","volume":"22","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Yang G, Qu C, et al. Predictive performance of lipid parameters in identifying undiagnosed diabetes and prediabetes: a cross-sectional study in eastern China. BMC Endocr Disord. 2022;22(1):76. https:\/\/doi.org\/10.1186\/s12902-022-00984-x.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2046_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-021-01348-w","volume":"20","author":"S Sokooti","year":"2021","unstructured":"Sokooti S, Flores-Guerrero JL, Heerspink HJL, et al. Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study. Cardiovasc Diabetol. 2021;20(1):156. https:\/\/doi.org\/10.1186\/s12933-021-01348-w.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"2046_CR21","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1210\/en.2009-0252","volume":"150","author":"S R\u00fctti","year":"2009","unstructured":"R\u00fctti S, Ehses JA, Sibler RA, et al. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic \u03b2-cells. Endocrinology. 2009;150(10):4521\u201330. https:\/\/doi.org\/10.1210\/en.2009-0252.","journal-title":"Endocrinology"},{"issue":"4","key":"2046_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrendo.2011.235","volume":"8","author":"BG Drew","year":"2012","unstructured":"Drew BG, Rye K-A, Duffy SJ, Barter P, Kingwell BA. The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol. 2012;8(4):237\u201345. https:\/\/doi.org\/10.1038\/nrendo.2011.235.","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 1","key":"2046_CR23","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.2337\/diabetes.50.2007.s118","volume":"50","author":"RH Unger","year":"2001","unstructured":"Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes. 2001;50(Suppl 1):S118-121. https:\/\/doi.org\/10.2337\/diabetes.50.2007.s118.","journal-title":"Diabetes"},{"issue":"2","key":"2046_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1161\/01.atv.0000054658.91146.64","volume":"23","author":"PJ Barter","year":"2003","unstructured":"Barter PJ, Brewer HB Jr, Chapman MJ, et al. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(2):160\u20137. https:\/\/doi.org\/10.1161\/01.atv.0000054658.91146.64.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2046_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/01.atv.16.12.1430","volume":"16","author":"B F\u00f6ger","year":"1996","unstructured":"F\u00f6ger B, Ritsch A, Doblinger A, et al. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol: studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 1996;16(12):1430\u20136. https:\/\/doi.org\/10.1161\/01.atv.16.12.1430.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2046_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2013.12.013","volume":"233","author":"N Li","year":"2014","unstructured":"Li N, Fu J, Koonen DP, et al. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis. 2014;233(1):130\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.12.013.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2046_CR27","first-page":"42","volume":"40","author":"WR Hazzard","year":"1985","unstructured":"Hazzard WR. Atherogenesis: why women live longer than men. Geriatrics. 1985;40(1):42\u201351.","journal-title":"Geriatrics"},{"issue":"3","key":"2046_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.genm.2010.05.002","volume":"7","author":"T Dayspring","year":"2010","unstructured":"Dayspring T, Pokrywka G. Impact of triglycerides on lipid and lipoprotein biology in women. Gend Med. 2010;7(3):189\u2013205. https:\/\/doi.org\/10.1016\/j.genm.2010.05.002.","journal-title":"Gend Med"},{"issue":"4","key":"2046_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2174\/138945009787846452","volume":"10","author":"GD Kolovou","year":"2009","unstructured":"Kolovou GD, Anagnostopoulou KK, Kostakou PM, et al. Primary and secondary hypertriglyceridaemia. Curr Drug Targets. 2009;10(4):336\u201343. https:\/\/doi.org\/10.2174\/138945009787846452.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"2046_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/nu12010202","volume":"12","author":"S-H Ko","year":"2020","unstructured":"Ko S-H, Kim H-S. Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women. Nutrients. 2020;12(1):202. https:\/\/doi.org\/10.3390\/nu12010202.","journal-title":"Nutrients"},{"issue":"2","key":"2046_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","volume":"3","author":"JE Hokanson","year":"1996","unstructured":"Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213\u20139.","journal-title":"J Cardiovasc Risk"},{"issue":"8","key":"2046_CR32","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.2337\/db08-1685","volume":"58","author":"G Maskarinec","year":"2009","unstructured":"Maskarinec G, Eeber E, Grandinetti A, et al. Diabetes incidence based on linkages with health plans: the multiethnic cohort. Diabetes. 2009;58(8):1732\u20138. https:\/\/doi.org\/10.2337\/db08-1685.","journal-title":"Diabetes"},{"issue":"8","key":"2046_CR33","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.2337\/diacare.26.8.2341","volume":"26","author":"A Katsuki","year":"2003","unstructured":"Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care. 2003;26(8):2341\u20134. https:\/\/doi.org\/10.2337\/diacare.26.8.2341.","journal-title":"Diabetes Care"},{"issue":"21","key":"2046_CR34","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195\u2013207. https:\/\/doi.org\/10.1056\/NEJMoa0807646.","journal-title":"N Engl J Med"},{"issue":"24","key":"2046_CR35","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1001\/jama.2011.860","volume":"305","author":"D Preiss","year":"2011","unstructured":"Preiss D, Seshasai SRK, Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011;305(24):2556\u201364. https:\/\/doi.org\/10.1001\/jama.2011.860.","journal-title":"JAMA"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02046-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:06:15Z","timestamp":1699459575000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02046-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2046"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02046-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Panasonic Health Insurance Organization's local ethics committee (permission number: 2021\u2013001) and was carried out in conformity with the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Hamaguchi M received grants from Ono Pharma Co. Ltd., AstraZeneca K.K., Oishi Kenko inc., Nippon Boehringer Ingelheim Co. Ltd., Yamada Bee Farm. Fukui M received grants from Oishi Kenko inc., Ono Pharma Co. Ltd., Yamada Bee Farm, Kissei Pharma Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Mitsubishi Tanabe Pharma Corp., Sanofi K.K., Daiichi Sankyo Co. Ltd., Astellas Pharma Inc., Kyowa Kirin Co. Ltd., MSD K.K., Sumitomo Pharma Co. Ltd., Novo Nordisk Pharma Ltd., Kowa Pharma Co. Ltd., Sanwa Kagagu Kenkyusho CO., Ltd., Taisho Pharma Co., Eli Lilly, Japan, K.K., Terumo Corp., Nippon Chemiphar Co. Ltd., Tejin Pharma Ltd., Abbott Japan Co. Ltd., Medical Co., Johnson & Johnson K.K, TERUMO Co.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}